Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Tuesday, May 21, 2024 · 713,370,727 Articles · 3+ Million Readers

PANDAS Physicians Network Welcomes Dritan Agalliu, PhD to the Scientific Advisory Board

Dritan Agalliu

Dritan Agalliu, PhD Joins PPN Scientific Advisory Board

PPN expands its Scientific Advisory Board by welcoming Dr Dritan Agalliu, Associate Professor of Pathology and Cell Biology and Neurology at Columbia University

Dr. Dritan Agalliu's research will lead to innovative, new treatments for those suffering from infection triggered neuropsychiatric symptoms. His findings will impact generations of children.”
— Susan Boaz, PPN Executive Director

MOORESVILLE, NC, USA, April 16, 2024 /EINPresswire.com/ -- PANDAS Physicians Network, a Division of the Foundation for Brain Science and Immunology, welcomes Dritan Agalliu, PhD to the PPN Scientific Advisory Board.

Dr. Agalliu is an Associate Professor of Pathology and Cell Biology and Neurology with tenure at Columbia University Irving Medical Center, New York, whose research focuses on the blood-brain barrier in the central nervous system and the mechanisms of neurovascular barrier breakdown in a variety of neuroimmune and neurodegenerative diseases, including PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) and PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections). He is the recipient of multiple grants from the National Institutes of Health (National Institute of Mental Health, National Institutes of Neurological Disorders and Stroke, National Eye Institute and National Heart, Lung and Blood Institute) as well as private foundations.

“We are very pleased to welcome Dr. Agalliu to the PANDAS Physicians Network Scientific Advisory Board,” said Susan Boaz, Executive Director of the PANDAS Physicians Network, “Groundbreaking research from the Agalliu lab on PANS/PANDAS and basal ganglia encephalitis will lead to innovative, new treatments for those suffering from infection triggered neuropsychiatric symptoms. His findings will impact generations of children.”

Dr. Agalliu will bring to the Scientific Advisory Board over 25 years of research experience in cellular and molecular neuroscience, neuroimmunology, cerebrovascular biology as well as translational neuroscience. He has a strong expertise with pre-clinical studies in rodent models for neurological disease and has published numerous research articles in prestigious journals (e.g. Nature, Cell, Nature Neuroscience, Nature Communications, Neuron, PNAS), trained a large number of postdoctoral scientists and graduate students, and has spoken at various international conferences around the globe, including those for PANS/PANDAS.

To read about Dr. Agalliu’s PANS/PANDAS research, please visit https://www.pandasppn.org/agalliu.

PANDAS Physicians Network is a non-profit organization that provides PANS/PANDAS resources to clinicians while supporting research. Our vision is that PANS/PANDAS will become easily diagnosed and treated with accessible therapies that dramatically reduce suffering and lead to a cure. www.pandasppn.org.

Media Relations
PANDAS Physicians Network
support@pandasppn.org
Visit us on social media:
Facebook
Twitter
Instagram
YouTube

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release